BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31832860)

  • 1. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study.
    Yılmaz A; Mirili C; Tekin SB; Bilici M
    Ir J Med Sci; 2020 Feb; 189(1):91-102. PubMed ID: 31832860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer.
    Yılmaz A; Yılmaz H; Tekin SB; Bilici M
    Biomark Med; 2020 Jun; 14(9):727-738. PubMed ID: 32648774
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy.
    Yilmaz H; Demirag G; Sullu Y; Yilmaz A
    J Coll Physicians Surg Pak; 2021 May; 31(5):546-552. PubMed ID: 34027867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
    Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
    Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
    Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
    Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.
    Chen L; Zuo Y; Zhu L; Zhang Y; Li S; Ma F; Han Y; Song H; Xue Y
    Onco Targets Ther; 2017; 10():2569-2580. PubMed ID: 28553122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer.
    Cheng S; Han F; Wang Y; Xu Y; Qu T; Ju Y; Lu Z
    BMC Gastroenterol; 2017 Dec; 17(1):163. PubMed ID: 29262773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
    Bozkaya Y; Kurt B; Gürler F
    Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.
    Chen L; Yan Y; Zhu L; Cong X; Li S; Song S; Song H; Xue Y
    Cancer Manag Res; 2017; 9():849-867. PubMed ID: 29276407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling Nutritional Status (CONUT) Score Is a Prognostic Factor for Patients with Gastric Cancer Treated by Perioperative FLOT.
    Akagunduz B; Demir M; Atcı MM
    J Gastrointest Cancer; 2022 Sep; 53(3):571-580. PubMed ID: 34263428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.
    el Aziz LM
    Med Oncol; 2014 Dec; 31(12):311. PubMed ID: 25367855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
    Chen JL; Wu JN; Lv XD; Yang QC; Chen JR; Zhang DM
    PLoS One; 2020; 15(8):e0237947. PubMed ID: 32833961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer.
    Yılmaz H; Yılmaz A; Demirağ G
    Future Oncol; 2021 Oct; 17(29):3853-3864. PubMed ID: 34382414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.
    Chen L; Hao Y; Cong X; Zou M; Li S; Zhu L; Song H; Xue Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819829485. PubMed ID: 30760114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.
    Mirili C; Yılmaz A; Demirkan S; Bilici M; Basol Tekin S
    Int J Clin Oncol; 2019 Oct; 24(10):1301-1310. PubMed ID: 31073814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT.
    McNamee N; Nindra U; Shahnam A; Yoon R; Asghari R; Ng W; Karikios D; Wong M
    J Gastrointest Oncol; 2023 Apr; 14(2):494-503. PubMed ID: 37201072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer.
    Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y
    Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
    Front Immunol; 2022; 13():831848. PubMed ID: 35320931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.